{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f479e4b62ffcb0e230eadfe/634fbb0c575a570012ff423f?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"S2#4 Health equality: fighting for testing and treatment among migrant and refugee populations","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/undefined/1598528985308-fa78c4fee16bf6485d75d0e4a645e3ce.jpeg?height=200","description":"<p>“I never felt the need of sharing my story at work, because I don't know how much they know about hepatitis B, and the moment they know that hepatitis B is contagious they would judge me” says Sidney Vo, a hepatitis B advocate who found out she was living with hepatitis B when she was pregnant with&nbsp;her son in her home country of Vietnam in 2007. A year later, she moved to Australia to help fill the gap in their workforce in early childhood education. After a decade of living in the country&nbsp;Sidney&nbsp;applied for permanent residency, only to find she was met with barriers from the government. In the final episode of the Hep-cast series 2 , Sidney Vo joins Professor Maria Buti from Hospital General Universitari Valle Hebron, Barcelona, Professor Mohammad Ali from the National Liver Foundation of Bangladesh (NLFB) and Camila Picchio, a public health researcher from Barcelona Institute for Global Health (ISGlobal) to discuss the challenges and barriers to accessing testing in a traditional healthcare setting and key considerations that are needed to reach migrants and refugees populations. </p><p><br></p><p><em>The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.</em></p><p><br></p><p>Job bag number: IHQ-UNB-2679</p><p>Date of preparation: September 2022</p>","author_name":"World Hepatitis Alliance and Gilead Sciences Europe Limited"}